These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2420302)

  • 1. Cerebrospinal fluid monoamine and monoamine metabolite levels and the dexamethasone suppression test in depression. Relationship to life events.
    Roy A; Pickar D; Linnoila M; Doran AR; Paul SM
    Arch Gen Psychiatry; 1986 Apr; 43(4):356-60. PubMed ID: 2420302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
    Roy A; Pickar D; Linnoila M; Doran AR; Ninan P; Paul SM
    Psychiatry Res; 1985 Aug; 15(4):281-92. PubMed ID: 2415996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB; Starkstein SE; Votypka V; Parikh RM; Price TR; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):440-2. PubMed ID: 1384852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
    Molchan SE; Hill JL; Mellow AM; Lawlor BA; Martinez R; Sunderland T
    Int Psychogeriatr; 1990; 2(2):99-122. PubMed ID: 1713799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical features of depression in Parkinson's disease.
    Mayeux R; Stern Y; Williams JB; Cote L; Frantz A; Dyrenfurth I
    Am J Psychiatry; 1986 Jun; 143(6):756-9. PubMed ID: 2424323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF GABA in depressed patients and normal controls.
    Roy A; Dejong J; Ferraro T
    Psychol Med; 1991 Aug; 21(3):613-8. PubMed ID: 1719577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF dopamine increased in depression: CSF dopamine, noradrenaline and their metabolites in depressed patients and in controls.
    Gjerris A; Werdelin L; Rafaelsen OJ; Alling C; Christensen NJ
    J Affect Disord; 1987; 13(3):279-86. PubMed ID: 2960721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors.
    Lu RB; Ho SL; Ho BT; Leu SY; Shian LR; Chen WL
    J Affect Disord; 1986; 10(3):177-84. PubMed ID: 2943770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression.
    Hallert C; Aström J; Sedvall G
    Scand J Gastroenterol; 1982 Jan; 17(1):25-8. PubMed ID: 6182605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study.
    Roy A; De Jong J; Linnoila M
    Arch Gen Psychiatry; 1989 Jul; 46(7):609-12. PubMed ID: 2472124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
    Koyama T; Lowy MT; Meltzer HY
    Am J Psychiatry; 1987 Mar; 144(3):334-7. PubMed ID: 2435178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
    Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function.
    Swann AC; Stokes PE; Secunda SK; Maas JW; Bowden CL; Berman N; Koslow SH
    Biol Psychiatry; 1994 May; 35(10):803-13. PubMed ID: 7519061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls.
    Roy A; Pickar D; Douillet P; Karoum F; Linnoila M
    Psychol Med; 1986 Aug; 16(3):541-6. PubMed ID: 3763772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.